Mammalian Target of Rapamycin and Caspase Inhibitors in Polycystic Kidney Disease

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.05611207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2012English

Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2014English

Retraction: Mammalian Target of Rapamycin Inhibitors for Treatment in Tuberous Sclerosis

Korean Journal of Pediatrics
Child HealthPediatricsPerinatology
2013English

Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
2010English

Tribbles Homolog 3 Attenuates Mammalian Target of Rapamycin Complex-2 Signaling and Inflammation in the Diabetic Kidney

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Polycystic Kidney Disease

Nature Reviews Disease Primers
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy